Kathryn Romano - Chief Accounting Officer at Krystal Biotech, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Issuer Symbol
KRYS on Nasdaq
All Insider Reports
All Insider Reports

Kathryn Romano - trading volume in the past year for Krystal Biotech, Inc.

Holdings reported by Kathryn Romano for Krystal Biotech, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 22,366 $5,985,141 $267.60 02 Mar 2026 Direct
Performance Stock Units 0 $1,322,925 $176.39 27 Feb 2026 Direct Common Stock
Restricted Stock Units 5,442 $388,058 $176.39 27 Feb 2026 Direct Common Stock
Stock Option (Right to Buy) 13,575 27 Feb 2026 Direct Common Stock

Transactions reported by Kathryn Romano for Krystal Biotech, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.